US20120323215A1 - System and method for administering medicaments on the basis of urine values - Google Patents

System and method for administering medicaments on the basis of urine values Download PDF

Info

Publication number
US20120323215A1
US20120323215A1 US13/578,799 US201113578799A US2012323215A1 US 20120323215 A1 US20120323215 A1 US 20120323215A1 US 201113578799 A US201113578799 A US 201113578799A US 2012323215 A1 US2012323215 A1 US 2012323215A1
Authority
US
United States
Prior art keywords
urine
values
patient
measured
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/578,799
Inventor
Hans-Otto Maier
Horst Schmoll
Matthias Paetzold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Assigned to B. BRAUN MELSUNGEN AG reassignment B. BRAUN MELSUNGEN AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MAIER, HANS-OTTO, SCHMOLL, HORST, PAETZOLD, MATTHIAS
Publication of US20120323215A1 publication Critical patent/US20120323215A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08Sensors provided with means for identification, e.g. barcodes or memory chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150229Pumps for assisting the blood sampling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150236Pistons, i.e. cylindrical bodies that sit inside the syringe barrel, typically with an air tight seal, and slide in the barrel to create a vacuum or to expel blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150244Rods for actuating or driving the piston, i.e. the cylindrical body that sits inside the syringe barrel, typically with an air tight seal, and slides in the barrel to create a vacuum or to expel blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150389Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150503Single-ended needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150763Details with identification means
    • A61B5/150786Optical identification systems, e.g. bar codes, colour codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/155Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6009General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/201Glucose concentration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584Control arrangements for automatic analysers
    • G01N35/00722Communications; Identification
    • G01N35/00871Communications between instruments or with remote terminals
    • G01N2035/00881Communications between instruments or with remote terminals network configurations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

The invention relates to a system and a method for administering medicaments to a patient, comprising: at least a first measuring device (7, 8) for measuring urine values of the urine of a patient (2); at least a first evaluation device (6) for evaluating the measured urine values (6 a); at least a first calculating device (13) for calculating first medicament parameters of the medicaments to be administered to the respective patient (2) on the basis of the evaluated, measured urine values (6 a); and at least one delivery device (1) for delivering the respective medicaments with calculated, common medicament parameters.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a U.S. National Stage application under 35 U.S.C. §371 of International Application No. PCT/EP2011/053245, filed Mar. 3, 2011, which claims the benefit of German Application Nos. 10 2010 010 567.8, filed Mar. 5, 2010, and 10 2010 012 733.7, filed Mar. 24, 2010.
  • The invention concerns a system and a method for administering medicaments to a patient.
  • Patients, in particular in intensive care units, are conventionally treated with medicaments and where applicable synthetic nutrition by means of one or more supply devices, for example intravenously. Supply devices can be infusion pumps which keep the vital blood values of the patient at a predeterminable level in reaction to a blood picture/blood gas analysis previously performed in the blood circulation of the patient.
  • All supply devices of this type, also when integrated into a system for administering medicaments and/or nutrients, have previously required the input of values by a doctor or further clinical personnel to form the basis for the supply by means of the supply device. For example here quantity values, time intervals at which the supply should be made, intermittent supply etc. are entered as the basis for subsequent supply of medicaments.
  • This supply is preceded by a usually manual taking of a blood specimen from the patient, which requires the intervention of clinical personnel. Also further clinical personnel is required with the necessary professional knowledge of the input functions of the supply device, such as the infusion pump, in order to subsequently perform this supply.
  • Usually such infusion therapies, in particular when involving urine values, are not determined to targeted values today. Rather the usual procedure is to set an infusion rate on the basis of a urine value status and/or a blood value status based on the experience of the clinical personnel and/or prespecified standards, protocols, instructions, specifications or similar.
  • Consequently the object of the invention is to provide a system and method for administration of medicaments to a patient which, also taking into account urine values, allows a supply of medicaments with the correct medicament parameters in an automated manner.
  • This object is achieved by the system with the features of claim 1 and by the method with the features of claim 10.
  • The core concept of the invention is that a system for administering medicaments to a patient contains the following devices:
      • at least one first measurement device to measure the urine values of the patient's urine;
      • at least one first analysis device to analyse the urine values measured;
      • at least one first calculation device to calculate first medicament parameters of the medicaments to be administered on the basis of the urine values analysed and measured; and
      • at least one supply device to supply the respective medicaments with the common calculated medicament parameters.
  • Such a system advantageously allows measured urine values to be taken into account in calculating the medicament parameters of the medicaments to be administered by the supply device. For example by means of the analysis and calculation device, the active substance furosemide can be administered to the patient automatically by means of the supply device as a function of the previously measured urine and blood values. This allows an additional control of the values measured for optimised administration of the active substance and for optimised setting of the infusion rate, wherein instead of the active substance furosemide, other medicaments can also be supplied.
  • It is also possible that competing values, for example urea, creatinine, lysc etc. from the urine value measurement and blood analysis evaluation are detected and can be corrected automatically by the calculation device. The calculation device can also take into account differences occurring in the relation between individual measured values and between these values, in calculating the optimised infusion value and hence does not rely on measurement of absolute values. Also the calculation device in calculating the infusion values, for example an infusion rate, can take into account the chronology and sequence of the previously measured values of this patient and their relative importance.
  • The urine values measured by the first measurement device can, as well as the said values, be further urine values for example the pH value, the protein content, the glucose content of the urine, the nitrite content of the urine, the bilirubin content of the urine, the ketone content of the urine, the bacteria content of the urine and/or the urine sediment results.
  • Advantageously a second measurement device measures the quantity of urine eliminated by the patient and a connected second analysis device can be used to analyse the urine quantity measured. Also the second measurement device can also measure the quantity of secretion from the patient's wounds and the second analysis device can analyse this accordingly.
  • This serves to ensure that by means of a second calculation device, a fluid balance of the patient's body can be calculated from the quantity of fluids eliminated and fluids supplied. The fluids eliminated can for example be the measured urine quantity previously analysed and the measured secretion quantity analysed, and the fluids supplied can be liquid medicaments supplied. Second medicament parameters are calculated from this.
  • A third measurement device serves to measure vital values of the patient such as ECG, EEG and similar data and a connected analysis device serves to analyse the vital values measured. By means of a third calculation device, third medicament parameters are calculated on the basis of the measured vital values analysed.
  • Advantageously in an automated manner by means of a common calculation device, the common medicament parameters can be calculated from the first, second and third medicament parameters. This has the consequence that all medicament parameters resulting from the calculated urine values, calculated blood values, fluid balance values and vital values can be taken into account to calculate optimised common medicament parameters in order to initiate the infusion with the optimised infusion rate.
  • Advantageously with the first measurement device, the patient's blood values can also be measured which can be analysed by the first analysis device and used by the first calculation device to calculate the first medicament parameters.
  • Thus taking into account a large number of measured values, in particular taking into account the urine values, an automated function of the complete system and an associated method for administering medicaments should be provided, wherein the transfer of the respective values, medicament parameters and other data can take place automatically. It is also conceivable that the medicament parameters and nutrient parameters determined for the proposed infusion for treatment of the patient can be displayed as proposed parameters or respectively data to support the clinical personnel on a corresponding display on the bed of the patient to be treated, so that the clinical personnel can set up the infusion pump by means of these displayed and entered data to the patient.
  • To ensure an automated secure transfer from the individual measurement devices, analysis devices and calculation devices to each other and to the infusion system, which can for example be one or more infusion pumps, these data are transferred by means of a data protocol which contains the patient ID, the time the measurement was taken, the time the specimens were taken, the identification of the measurement device concerned, the quality class of the measurement device as well as further quality features.
  • It is also advantageous that the fluid balance takes place automatically and the determination of eliminated fluids is not carried out by means of complicated weighing techniques. Rather more, the quantity of all eliminated measurable fluids is determined preferably automatically and the remaining fluids lost by the human body are simulated by calculation. These eliminated fluids are compared with the fluids supplied in the form of liquid medicaments or nutrients which can easily be determined.
  • In the method according to the invention for administration of medicaments to a patient, the following steps are performed:
      • measurement of urine values of a patient's urine by at least one first measurement device;
      • analysis of the measured urine values by at least one first analysis device;
      • calculation of first medicament parameters of the medicaments to be administered to the respective patient on the basis of the measured urine values analysed, by means of at least one first calculation device; and
      • supply of the respective medicament with calculated common medicament parameters by means of at least one supply device.
  • According to a preferred embodiment, in the method according to the invention a fluid balance of the patient's body is calculated and/or determined and carried out by measurement and calculation of the eliminated fluids and measurement and calculation of the supplied fluids.
  • Further advantageous embodiments arise from the subclaims.
  • Advantages and features arise from the description below in conjunction with the drawing.
  • The only FIGURE is a diagrammatic depiction of the system for administration of medicaments according to one embodiment of the invention.
  • The system shown in this FIGURE for the automated administration of medicaments (for example active substances or drugs such as furosemide, insulin etc.) is an automatic infusion system 1 with a multiplicity of infusion pumps for the treatment of individual incorrectly set values within the body of the patient 2.
  • A patient 2 in intensive care thus according to reference numeral 3 receives from the automated infusion system 1 medicaments with the associated infusion rates, where applicable taking into account a change in medicament quantity, administration period and further parameters.
  • The patient 2 in intensive care can be analysed in various aspects, as priority in his urine values, by means of one or more measurement devices 4, 7, 8, or 9.
  • For example by means of the measurement devices 8 the urine values and/or blood values can be measured automatically at the intensive care unit by the taking of urine and blood specimens from the patient 2. Individually, according to reference numeral 6 a, the urine values are the pH value of the urine, the protein content of the urine, the glucose content of the urine, the nitrite content of the urine, the bilirubin content of the urine, the ketone content of the urine, the bacteria content of the urine and the urine sediment results. The blood values are individually the glucose value, the lactate value, the electrolyte value (Na+, CL+, K+). the pO2 value, the pCO2 value, the medicament level values, the calcium antagonist values (blood pressure) and the propofol values (sedation).
  • The blood values are shown according to reference numeral 6 b.
  • In addition, the urine and secretion quantity values can be measured, preferably automatically, by means of a second measurement device 9. From these, the urine quantity and secretion quantity values are determined by means of analysis device 10.
  • By means of a third measurement device 4, preferably by means of sensors, automatically vital parameters such as ECG and EEG values and similar values are determined which are analysed in a third analysis device 5.
  • The analysed values from all analysis devices 5, 6 and 10 are transmitted preferably automatically to a respective associated first, second and third calculation device 11, 12 and 13. The transfer takes place according to reference numerals 14, 21 and 22 by means of a data protocol which additionally comprises data such as the patient identification numbers, the time the measurement was performed, the time the specimen was taken, the identification of the respective measurement device, the quality class of the measurement device and an allocated quality feature.
  • In the calculation device 11, a calculation is performed of the relevant medicament parameters and nutrient parameters for the administration of medicaments and/or nutrition with the infusion system 1. Here, for a fluid balance to be performed, a balance is produced of all eliminated fluids i.e. for example the measured secretion quantity and urine quantity, and the fluids supplied such as for example the liquid medicaments and liquid nutrition according to the supply device 1.
  • The following comments apply to such a fluid balance of infused fluids versus eliminated fluids:
  • Human beings are known to eliminate fluids in various ways. Firstly, urine quantities and wound secretion quantities are eliminated which can be measured automatically and directly for patients in intensive care. In addition to the directly measurable fluids, there are further fluids which can be established indirectly such as water vapour eliminated by respiration, transpiration through the skin of the body and fluid elimination by faeces and similar. These fluid quantities are determined by means of physiological models taking into account the body surface area, body temperature and similar.
  • With the calculation device 12, the second medicament parameters can be calculated for the medicament to be administered by means of the infusion system 1 and where applicable associated nutrients.
  • By means of calculation device 13, on the basis of the urine and/or blood values measured, the medicament parameters and nutrient parameters can be calculated for the medicaments and nutrients to be administered by means of the infusion system 1.
  • The calculated medicament parameters and nutrient parameters are transmitted according to reference numerals 15, 16 and 17 to the infusion system 1, hard-wired or wirelessly, preferably encrypted.
  • On a change of infusion rates of the infusions or respectively medicaments and/or nutrients to be administered, a feedback takes place to the calculation device 11, 12 and 13 according to reference numerals 18, 19 and 20 so that these changes can be taken into account in the recalculation of medicament parameters and/or nutrient parameters.
  • All calculation devices 11, 12 and 13 are combined within a common calculation device.
  • By the way, also the urine values and blood values can be determined by means of a measurement device 7 within a laboratory.
  • Insofar as competing values are measured by the different measurement devices, the calculation devices 11, 12 and 13 can take these into account and apply a corresponding correction, taking into account the weighting of the individual measurement devices and the values measured therewith.
  • It is also conceivable that the calculation devices take into account the chronology of measurements, the sequence of measurements and the quality of measurements in determining the medicament parameters and/or nutrient parameters. Also relations and differences of individually determined values in relation to each other and to other values from other measurement devices are taken into account in determining the medicament parameters and/or the nutrient parameters.
  • Certain features disclosed in the application are understood to be novel, including for example, features either individually or in combination with other features as compared with the prior art.
  • LIST OF REFERENCE NUMERALS
    • 1 Infusion system
    • 2 Patient
    • 3 Medicaments
    • 4 Third measurement device
    • 5 Third analysis device
    • 6 First analysis device
    • 6 a Urine values
    • 6 b Blood values
    • 7 First measurement device in laboratory
    • 8 First measurement device at intensive care unit
    • 9 Second measurement device
    • 10 Second analysis device
    • 11 First calculation device
    • 12 Second calculation device
    • 13 Third calculation device
    • 14 Transfer of values by means of data protocol
    • 15 Transfer of medicament and nutrient parameters to the infusion system
    • 16 Transfer of medicament and nutrient parameters to the infusion system
    • 17 Transfer of medicament and nutrient parameters to the infusion system
    • 18 Feedback to calculation device
    • 19 Feedback to calculation device
    • 20 Feedback to calculation device
    • 21 Transfer of values by means of data protocol
    • 22 Transfer of values by means of data protocol

Claims (12)

1. A system for administration of medicaments for a patient comprising:
at least one first measurement device to measure urine values of the urine of the patient;
at least one first analysis device to analyse the measured urine values;
at least one first calculation device to calculate first medicament parameters of the medicaments to be administered to the patient on the basis of the measured urine values analysed; and
at least one supply device to supply the medicaments with calculated common medicament parameters.
2. The system according to claim 1, wherein the urine values, are selected from the group consisting of the pH value of the urine, the protein content of the urine, the glucose content of the urine, the nitrate content of the urine, the bilirubin content of the urine, the ketone content of the urine, the bacteria content of the urine and the urine sediment.
3. The system according to claim 1, further comprising a second measurement device to measure the quantity of urine eliminated by the patient and a second analysis device connected thereto to analyse the urine quantity measured.
4. The system according to claim 3, wherein the quantity of secretion eliminated from wounds of the patient can be measured with the second measurement device and analysed by the second analysis device.
5. The system according to claim 3, further comprising a second calculation device to calculate a fluid balance of the body of the patient from a quantity of fluids eliminated, including the measured urine quantity analysed and the measured secretion quantity analysed, and from a quantity of fluids supplied, including the supplied liquid medicaments, and to calculate second medicament parameters.
6. The system according to claim 1, further comprising a third measurement device to measure vital values of the patient, and a third analysis device connected thereto to analyse the vital values measured.
7. The system according to claim 6, further comprising a third calculation device to calculate third medicament parameters on the basis of the measured vital values analysed.
8. The system according to claim 7, further comprising a common calculation device which calculates the common medicament parameters from the first, second and third medicament parameters.
9. The system according to claim 1, wherein blood values of the patient can be measured with the first measurement device and analysed by the first analysis device and used by the first calculation device to calculate the first medicament parameters.
10. A method for administering medicaments to a patient comprising the following steps:
measurement of urine values of the urine of the patient by at least one first measurement device;
analysis of the measured urine values by at least one first analysis device;
calculation of first medicament parameters of the medicaments to be administered to the patient on the basis of the measured urine values analysed, by means of at least one first calculation device; and
supply of the medicaments with calculated common medicament parameters by means of at least one supply device.
11. The method according to claim 10, wherein a fluid balance of the body of the patient is calculated by measurement and calculation of eliminated fluids and measurement and calculation of supplied fluids.
12. The system according to claim 6, wherein the vital values of the patient are selected from the group consisting of ECG and EEG.
US13/578,799 2010-03-05 2011-03-03 System and method for administering medicaments on the basis of urine values Abandoned US20120323215A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102010010567 2010-03-05
DE102010010567.8 2010-03-05
DE102010012733.7 2010-03-24
DE102010012733 2010-03-24
PCT/EP2011/053245 WO2011107568A1 (en) 2010-03-05 2011-03-03 System and method for administering medicaments on the basis of urine values

Publications (1)

Publication Number Publication Date
US20120323215A1 true US20120323215A1 (en) 2012-12-20

Family

ID=43920342

Family Applications (6)

Application Number Title Priority Date Filing Date
US13/577,017 Abandoned US20130023851A1 (en) 2010-03-05 2011-03-03 System and method for administering medicaments to a patient
US13/521,713 Abandoned US20130023819A1 (en) 2010-03-05 2011-03-03 System and method for monitoring at least one blood parameter
US13/575,857 Abandoned US20120316465A1 (en) 2010-03-05 2011-03-03 System and method for monitoring the time period for blood parameter monitoring processes
US13/581,225 Abandoned US20120323141A1 (en) 2010-03-05 2011-03-03 System for determining treatment-related data for the administration of drugs to patients to be treated taking into account important individual factors
US13/578,799 Abandoned US20120323215A1 (en) 2010-03-05 2011-03-03 System and method for administering medicaments on the basis of urine values
US13/579,858 Active 2033-11-09 US9861745B2 (en) 2010-03-05 2011-03-03 System and method for monitoring time intervals during blood parameter monitoring

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US13/577,017 Abandoned US20130023851A1 (en) 2010-03-05 2011-03-03 System and method for administering medicaments to a patient
US13/521,713 Abandoned US20130023819A1 (en) 2010-03-05 2011-03-03 System and method for monitoring at least one blood parameter
US13/575,857 Abandoned US20120316465A1 (en) 2010-03-05 2011-03-03 System and method for monitoring the time period for blood parameter monitoring processes
US13/581,225 Abandoned US20120323141A1 (en) 2010-03-05 2011-03-03 System for determining treatment-related data for the administration of drugs to patients to be treated taking into account important individual factors

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/579,858 Active 2033-11-09 US9861745B2 (en) 2010-03-05 2011-03-03 System and method for monitoring time intervals during blood parameter monitoring

Country Status (14)

Country Link
US (6) US20130023851A1 (en)
EP (6) EP2542991A1 (en)
JP (6) JP5592506B2 (en)
CN (5) CN102713615A (en)
AU (6) AU2011222944B2 (en)
BR (6) BR112012019624A2 (en)
CA (6) CA2788603C (en)
ES (2) ES2655370T3 (en)
IL (6) IL220765B (en)
MX (6) MX2012009058A (en)
PL (1) PL2542142T3 (en)
RU (6) RU2530590C2 (en)
SG (6) SG183354A1 (en)
WO (6) WO2011107569A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US10492991B2 (en) 2010-05-30 2019-12-03 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US9514131B1 (en) * 2010-05-30 2016-12-06 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10262112B2 (en) 2013-02-04 2019-04-16 Precera Bioscience, Inc. Prescription decision support system and method using comprehensive multiplex drug monitoring
DE102014105058A1 (en) * 2014-04-09 2015-10-15 Stephanie Ittstein Device for production and / or administration
JP6391312B2 (en) * 2014-06-13 2018-09-19 クラリオン株式会社 Terminal connection apparatus, processing information execution system, and processing information execution method
US10525182B2 (en) 2014-10-10 2020-01-07 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11714975B2 (en) 2014-10-28 2023-08-01 Avery Dennison Retail Information Services Llc High density read chambers for scanning and encoding RFID tagged items
US20160314185A1 (en) * 2015-04-27 2016-10-27 Microsoft Technology Licensing, Llc Identifying events from aggregated device sensed physical data
DE102016005131A1 (en) * 2016-04-27 2017-11-02 Justus-Liebig-Universität Giessen Device and method for preventing misinsertion of a drug
US10045725B2 (en) * 2016-05-13 2018-08-14 Hugh Califf Blood analysis method and apparatus
CN109070953B (en) * 2016-05-20 2022-06-28 麦格纳外饰公司 Active bottom panel assembly
WO2018017623A1 (en) 2016-07-18 2018-01-25 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
US11752254B2 (en) 2016-09-20 2023-09-12 Bracco Diagnostics Inc. Radioisotope delivery system with multiple detectors to detect gamma and beta emissions
US11810685B2 (en) 2018-03-28 2023-11-07 Bracco Diagnostics Inc. Early detection of radioisotope generator end life
EP3669912A1 (en) * 2018-12-19 2020-06-24 Sanofi Drug delivery device and drug delivery system
CN115334977A (en) * 2020-03-27 2022-11-11 泰尔茂株式会社 Biological function estimating device and biological function estimating method
TWI811641B (en) * 2021-03-04 2023-08-11 宏碁股份有限公司 Medication risk evaluation method and medication risk evaluation device
US20230166033A1 (en) * 2021-11-30 2023-06-01 Tandem Diabetes Care, Inc. Bolus permissions and prioritization scheme for infusion pump system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4449538A (en) * 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
US5590648A (en) * 1992-11-30 1997-01-07 Tremont Medical Personal health care system
US20030114786A1 (en) * 2000-03-09 2003-06-19 Joachim Hiller Fluid counterbalancing system

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
JPS5521905A (en) * 1978-08-02 1980-02-16 Nikkiso Co Ltd Improvement of artificial pancreas
SU1458824A1 (en) * 1987-02-19 1989-02-15 Московский медицинский стоматологический институт им.Н.А.Семашко Method of determining disturbed activity of blood plasma fibrinogen
SU1686361A1 (en) * 1988-04-05 1991-10-23 Самарский медицинский институт им.Д.И.Ульянова Method for estimation of functional activity of donor blood cells
US5956501A (en) * 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
JP4389005B2 (en) * 1993-11-02 2009-12-24 ユー.ディー.テスティング.インコーポレイテッド How to monitor whether a patient is following a drug prescription
JP3243103B2 (en) * 1994-02-04 2002-01-07 吉彦 鈴木 Blood glucose control device
US7384410B2 (en) * 1995-03-13 2008-06-10 Cardinal Health 303, Inc. System and method for managing patient care
US5713856A (en) * 1995-03-13 1998-02-03 Alaris Medical Systems, Inc. Modular patient care system
JPH09329597A (en) * 1996-06-11 1997-12-22 Hitachi Ltd Urine sediment inspection system
JPH10274656A (en) * 1997-03-28 1998-10-13 Kdk Corp Measurement method of glucose concentration
US6579690B1 (en) * 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US7760187B2 (en) * 2004-07-30 2010-07-20 Apple Inc. Visual expander
US8480580B2 (en) * 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6074345A (en) * 1998-10-27 2000-06-13 University Of Florida Patient data acquisition and control system
RU2148257C1 (en) 1999-06-01 2000-04-27 Тверская государственная медицинская академия Method for examining blood
US6423035B1 (en) * 1999-06-18 2002-07-23 Animas Corporation Infusion pump with a sealed drive mechanism and improved method of occlusion detection
US6519569B1 (en) * 1999-12-01 2003-02-11 B. Braun Medical, Inc. Security infusion pump with bar code reader
US6790198B1 (en) * 1999-12-01 2004-09-14 B-Braun Medical, Inc. Patient medication IV delivery pump with wireless communication to a hospital information management system
US20030154108A1 (en) * 2000-03-01 2003-08-14 Gambro, Inc. Extracorporeal blood processing information management system
JP2001245874A (en) * 2000-03-03 2001-09-11 Sefa Technology Kk Blood collecting tube for measuring red corpuscle sedimentation speed, blood collecting tube holder, protector for carrying blood collecting tube, and method and device for measuring red corpuscle sedimentation speed
US7630908B1 (en) * 2000-05-01 2009-12-08 John Amrien Wireless electronic prescription scanning and management system
GB0030809D0 (en) * 2000-12-16 2001-01-31 Schmidt Paul Sample tracking systems
US6973374B2 (en) * 2000-12-19 2005-12-06 University Of Rochester Method and device for administering medication and/or placebo
JP4276834B2 (en) * 2000-12-27 2009-06-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Biological information and blood processing apparatus information management system
US20030032898A1 (en) * 2001-05-29 2003-02-13 Inder Raj. S. Makin Method for aiming ultrasound for medical treatment
AU2002365821A1 (en) * 2001-11-30 2003-06-17 British Telecommunications Public Limited Company Data transmission
RU2226689C2 (en) * 2001-12-27 2004-04-10 Медицинский радиологический научный центр РАМН Method for determining organism resistibility
US20030141981A1 (en) * 2002-01-29 2003-07-31 Tuan Bui System and method for operating medical devices
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
DE10226212A1 (en) * 2002-06-13 2003-12-24 Philips Intellectual Property Qualifying Examination System
DE20217847U1 (en) * 2002-11-19 2004-04-08 B. Braun Melsungen Ag Secretion collecting device
US20040172284A1 (en) 2003-02-13 2004-09-02 Roche Diagnostics Corporation Information management system
WO2004095379A1 (en) * 2003-04-23 2004-11-04 Vasogen Ireland Limited Dispensing systems
ZA200508816B (en) * 2003-04-23 2008-01-30 Vasogen Ireland Ltd Dispensing systems
US7258673B2 (en) * 2003-06-06 2007-08-21 Lifescan, Inc Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
US8998808B2 (en) * 2003-06-19 2015-04-07 Wayne State University System for identifying patient response to anesthesia infusion
US20050019943A1 (en) 2003-07-09 2005-01-27 Chaoui Sam M. Automatic blood analysis and identification system
US20050021368A1 (en) * 2003-07-25 2005-01-27 Debra Burkeen Enhanced safety medication administration system
US20050021367A1 (en) * 2003-07-25 2005-01-27 Deborah Saeger Medication administration system
JP2005102960A (en) * 2003-09-30 2005-04-21 Seiko Epson Corp Infusion support system, infusion support apparatus, infusion apparatus, and method of infusion
AR048660A1 (en) * 2003-11-21 2006-05-17 Vasogen Ireland Ltd SYSTEM FOR THE TREATMENT OF AN AUTOMATIC BLOOD SAMPLE AND MATERIAL DISPENSING DEVICE
US20050154368A1 (en) * 2003-11-21 2005-07-14 Vasogen Ireland Limited Medical material handling systems
EP1697883A1 (en) * 2003-11-21 2006-09-06 Vasogen Ireland Limited Medical treatment management systems
US7172115B2 (en) * 2004-04-02 2007-02-06 Riptide Systems, Inc. Biometric identification system
US8518021B2 (en) * 2004-05-27 2013-08-27 Baxter International Inc. Apparatus and method for therapeutic delivery of medication
US8359338B2 (en) * 2004-07-30 2013-01-22 Carefusion 303, Inc. System and method for managing medical databases for patient care devices
WO2006023985A2 (en) * 2004-08-23 2006-03-02 Remote Clinical Solutions, Inc. System and method for modifying a fluid for oral administration
US20060042634A1 (en) * 2004-08-31 2006-03-02 Nalagatla Anil K Device for connecting a cannula to a medical effector system
US7727222B2 (en) * 2004-09-09 2010-06-01 Plc Medical Systems, Inc. Patient hydration system with taper down feature
US20080027409A1 (en) * 2004-09-09 2008-01-31 Rudko Robert I Patient hydration/fluid administration system and method
RU2275640C1 (en) * 2004-09-20 2006-04-27 Илья Николаевич Медведев Method for selecting thrombocytopathy treatment approach in metabolic syndrome cases
WO2006086735A2 (en) * 2005-02-11 2006-08-17 Cardinal Health 303, Inc. Identification system and method for medication management
US7785258B2 (en) * 2005-10-06 2010-08-31 Optiscan Biomedical Corporation System and method for determining a treatment dose for a patient
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
KR100716015B1 (en) * 2005-06-08 2007-05-08 유재천 lancet device and method for sampling and injecting blood using same
US20070088333A1 (en) * 2005-10-13 2007-04-19 G&L Consulting, Llc Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate
US20070100256A1 (en) * 2005-10-28 2007-05-03 Sansom Gordon G Analyte monitoring system with integrated lancing apparatus
US8543420B2 (en) * 2007-09-19 2013-09-24 Fresenius Medical Care Holdings, Inc. Patient-specific content delivery methods and systems
US8140353B2 (en) 2006-06-29 2012-03-20 The Invention Science Fund I, Llc Compliance data for health-related procedures
US9015055B2 (en) * 2006-07-13 2015-04-21 Abbott Point Of Care Inc. Medical data acquisition and patient management system and method
CN1987962A (en) * 2006-09-27 2007-06-27 上海博维康讯信息科技发展有限公司 Disposable patient wrist band and patient identity identifying system
RU2316765C1 (en) * 2006-09-28 2008-02-10 Илья Николаевич Медведев Method for detecting antithrombotic blood vessel activity weakening at early stage
RU2328000C1 (en) * 2006-11-27 2008-06-27 Илья Николаевич Медведев Method of early detection of thromboplastin-formation
CN101610820B (en) * 2006-12-22 2012-02-01 科乐美数码娱乐株式会社 toy for shooting two-player games
US9326742B2 (en) * 2007-01-01 2016-05-03 Bayer Healthcare Llc Systems for integrated radiopharmaceutical generation, preparation, transportation and administration
JP2008224385A (en) 2007-03-12 2008-09-25 Olympus Corp Analyzer and analytical method
WO2008114224A2 (en) * 2007-03-19 2008-09-25 Insuline Medical Ltd. Method and device for substance measurement
US8412293B2 (en) * 2007-07-16 2013-04-02 Optiscan Biomedical Corporation Systems and methods for determining physiological parameters using measured analyte values
US8417311B2 (en) * 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
CA2688184A1 (en) 2007-06-08 2008-12-18 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20090004317A1 (en) * 2007-06-30 2009-01-01 Xuejiao Hu High thermal conductivity molding compound for flip-chip packages
US20090062730A1 (en) 2007-09-01 2009-03-05 San Hoon Woo Control of body fluid condition using diuretics, based on biological parameters
CN102670209A (en) * 2007-09-07 2012-09-19 泰尔茂株式会社 Blood sugar measuring method
DE102007047351A1 (en) * 2007-10-02 2009-04-09 B. Braun Melsungen Ag System and method for monitoring and controlling blood glucose levels
EP3868284A1 (en) 2007-10-10 2021-08-25 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
JP5188780B2 (en) * 2007-11-08 2013-04-24 日機装株式会社 Blood purification apparatus and treatment end notification method using the same
RU2371723C1 (en) * 2008-03-03 2009-10-27 Государственное учреждение Научный центр реконструктивной и восстановительной хирургии Восточно-Сибирского научного центра Сибирского отделения Российской Академии медицинских наук Method of assessment of erythrocyte resistance to functional stress
JP2009273502A (en) 2008-05-12 2009-11-26 Jms Co Ltd Medication monitoring apparatus
US20090307008A1 (en) * 2008-06-04 2009-12-10 Cardinalhealth Blood infusion management system and method
US20100036310A1 (en) 2008-08-05 2010-02-11 Hillman Robert S Integrated patient management and control system for medication delivery
US20100160854A1 (en) * 2008-12-22 2010-06-24 Gauthier Robert T Integrated patient management and control system for medication delivery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4449538A (en) * 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
US5590648A (en) * 1992-11-30 1997-01-07 Tremont Medical Personal health care system
US20030114786A1 (en) * 2000-03-09 2003-06-19 Joachim Hiller Fluid counterbalancing system

Also Published As

Publication number Publication date
BR112012021524A2 (en) 2016-07-05
RU2012132703A (en) 2014-02-10
CN102713615A (en) 2012-10-03
MX2012009373A (en) 2012-09-12
WO2011107568A1 (en) 2011-09-09
EP2542992B1 (en) 2017-11-08
IL221373A0 (en) 2012-10-31
EP2542142B1 (en) 2021-11-17
CA2789188A1 (en) 2011-09-09
CN102741850A (en) 2012-10-17
AU2011222943B2 (en) 2014-08-28
SG183354A1 (en) 2012-09-27
JP5758409B2 (en) 2015-08-05
WO2011107566A1 (en) 2011-09-09
AU2011222946A1 (en) 2012-08-16
EP2542151A1 (en) 2013-01-09
RU2530590C2 (en) 2014-10-10
ES2904601T3 (en) 2022-04-05
BR112012020270B1 (en) 2022-02-15
CA2789191A1 (en) 2011-09-09
US20120323141A1 (en) 2012-12-20
CA2788057A1 (en) 2011-09-09
RU2524121C2 (en) 2014-07-27
US20120316465A1 (en) 2012-12-13
SG183118A1 (en) 2012-09-27
CA2786302A1 (en) 2011-09-09
PL2542142T3 (en) 2022-03-21
IL221166A0 (en) 2012-09-24
EP2542151B1 (en) 2015-05-06
IL221412A0 (en) 2012-10-31
IL221009A (en) 2017-05-29
CA2789191C (en) 2017-10-31
IL221166B (en) 2018-06-28
CN102762144A (en) 2012-10-31
EP2542991A1 (en) 2013-01-09
IL221412A (en) 2016-07-31
IL221413A0 (en) 2012-10-31
EP2542886A1 (en) 2013-01-09
CA2788603C (en) 2017-05-23
JP2013519481A (en) 2013-05-30
JP5658767B2 (en) 2015-01-28
MX2012008822A (en) 2012-09-07
RU2012133280A (en) 2014-02-10
BR112012019133A2 (en) 2018-03-27
EP2542992A1 (en) 2013-01-09
JP2013520718A (en) 2013-06-06
MX2012008144A (en) 2012-08-03
AU2011222944B2 (en) 2013-12-19
ES2655370T3 (en) 2018-02-19
JP5592506B2 (en) 2014-09-17
BR112012020270A2 (en) 2016-05-03
CA2786302C (en) 2016-02-23
AU2011222945A1 (en) 2012-09-06
US20130023851A1 (en) 2013-01-24
JP2013521543A (en) 2013-06-10
IL220765A0 (en) 2012-08-30
JP2013520217A (en) 2013-06-06
US20130085471A1 (en) 2013-04-04
MX2012009598A (en) 2012-09-12
AU2011222942B2 (en) 2014-05-08
CN102762240A (en) 2012-10-31
BR112012021524B1 (en) 2021-10-13
SG183254A1 (en) 2012-09-27
WO2011107569A1 (en) 2011-09-09
RU2012127707A (en) 2014-01-20
US20130023819A1 (en) 2013-01-24
AU2011222943A1 (en) 2012-08-30
JP5485414B2 (en) 2014-05-07
IL221373A (en) 2015-06-30
CA2788057C (en) 2014-12-02
RU2012134289A (en) 2014-02-27
JP2013517030A (en) 2013-05-16
CN102762144B (en) 2015-07-08
BR112012019624A2 (en) 2016-05-03
RU2543941C2 (en) 2015-03-10
AU2011222946B2 (en) 2014-10-02
CN102804191A (en) 2012-11-28
IL220765B (en) 2018-04-30
EP2542276A1 (en) 2013-01-09
AU2011222947B2 (en) 2014-09-18
RU2012130366A (en) 2014-01-27
US9861745B2 (en) 2018-01-09
IL221413B (en) 2020-07-30
BR112012020923A2 (en) 2020-01-14
CN102834048B (en) 2016-03-30
SG183353A1 (en) 2012-09-27
RU2522270C2 (en) 2014-07-10
MX2012009596A (en) 2012-09-12
BR112012017543A2 (en) 2016-06-28
RU2526141C2 (en) 2014-08-20
CN102762240B (en) 2017-03-08
WO2011107570A1 (en) 2011-09-09
MX2012009058A (en) 2012-09-07
RU2517562C2 (en) 2014-05-27
CN102834048A (en) 2012-12-19
EP2542142A1 (en) 2013-01-09
CA2789188C (en) 2020-04-07
CA2787324A1 (en) 2011-09-09
CA2787324C (en) 2018-04-17
AU2011222942A1 (en) 2012-08-30
JP2013517871A (en) 2013-05-20
RU2012134290A (en) 2014-02-20
WO2011107567A1 (en) 2011-09-09
CA2788603A1 (en) 2011-09-09
SG183352A1 (en) 2012-09-27
AU2011222945B2 (en) 2014-02-06
AU2011222944A1 (en) 2012-08-30
WO2011107571A1 (en) 2011-09-09
SG182546A1 (en) 2012-08-30
AU2011222947A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
CA2788603C (en) System and method for administering medicaments on the basis of urine values
MX2012009377A (en) BENZISOXAZOLES AND AZABENZISOXAZOLES AS mgluR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION.
Hoss et al. Factory-calibrated continuous glucose sensors: the science behind the technology
JP5762500B2 (en) System for monitoring and adjusting blood glucose level and method for operating the same
Boom et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial
EP2217135B1 (en) Assessing residual insulin time
WO2012008544A1 (en) Hemodialysis system
CA2927004C (en) Improved transcutaneous organ function measurement
EP3145393B1 (en) Absolute blood volume estimation using hemodilution
JP2015512698A (en) Apparatus for performing anesthesia or analgesia and method of operating the apparatus for performing anesthesia or analgesia
Poliquin et al. Delivering prolonged intensive care to a non-human primate: a high fidelity animal model of critical illness
EP2194474A1 (en) Drug delivery presentation and arrangement for drug delivery presentation
CN117558435B (en) Remote dialysis guiding system based on BCM equipment
Dubauskienė et al. Challenges of Close Loop Electronic Medical Systems
JP2024012156A (en) Automatic drug infusion monitoring device with timed sample
RU130851U1 (en) SYSTEM OF AUTOMATED MANAGEMENT OF PHYSIOLOGICAL STATE OF THE PATIENT
Mehta et al. Target controlled infusion for Kids: Trials and simulations
CN110730989A (en) Personalized renal failure chronic care system and method
Kramer et al. Presynaptic versus postsynaptic immobilization of the diaphragm: Effects on the acetylcholine and MuSK receptors: 12AP1–6

Legal Events

Date Code Title Description
AS Assignment

Owner name: B. BRAUN MELSUNGEN AG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAIER, HANS-OTTO;SCHMOLL, HORST;PAETZOLD, MATTHIAS;SIGNING DATES FROM 20120831 TO 20120904;REEL/FRAME:029050/0389

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION